Come up with a name for your new list and we'll add to it:
Gema Diagnostics raised a round of funding on March 27, 2013. Investors include
North Coast Technology Investors.
Gema Diagnostics aims to raise IVF birth rates by giving clinicians tools to select the most competent eggs (oocytes) and most viable embryos. GemART, the company's first clinical test, will identify …